Dr. Reddy's Laboratories signs a licensing deal with Ingenus Pharmaceuticals to commercialize Cyclophosphamide injection, a cancer treatment, in the US.
Indian pharma giant Dr. Reddy's Laboratories Ltd has signed a licensing agreement with US-based Ingenus Pharmaceuticals, LLC to commercialize Cyclophosphamide injection, a key cancer treatment. Dr. Reddy's USA gains exclusive rights to market the injection in three strengths within the US, while sharing 50% of profits with Ingenus. Ingenus previously recorded sales of $51.8 million in the past 12 months.
June 12, 2024
3 Articles